News
-
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Novembre 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Communiqué mensuel sur le nombre de droits de vote et d'actions de la société bioMérieux. Informations conformes à la réglementation financière en vigueur -
-
-
-
COMMUNIQUÉ DE PRESSE
Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
Vaderis Therapeutics announces publication of engasertib proof-of-concept study results in The New England Journal of Medicine, showing potential for Hereditary Hemorrhagic Telangiectasia patients -
COMMUNIQUÉ DE PRESSE
Hardman & Co research on Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty
Hardman & Co Research highlights Real Estate Credit Investments opportunities post Investor Day. Expertise in unique real estate lending sectors drives strong pipeline and good returns